Development and validation of a rapid LC-MS/MS method to quantify letrozole in human plasma and its application to therapeutic drug monitoring.

about

SPE-UPLC-MS/MS assay for determination of letrozole in human plasma and its application to bioequivalence study in healthy postmenopausal Indian women.

P2860

Q49657659-8F16BCE0-2E36-40F5-BA66-360C7BD32C7E

P2860

Development and validation of a rapid LC-MS/MS method to quantify letrozole in human plasma and its application to therapeutic drug monitoring.

Item

http://www.wikidata.org/entity/Q35758526

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Development and validation of ...... o therapeutic drug monitoring.

@ast

Development and validation of ...... o therapeutic drug monitoring.

@en

type

Item

label

Development and validation of ...... o therapeutic drug monitoring.

@ast

Development and validation of ...... o therapeutic drug monitoring.

@en

prefLabel

Development and validation of ...... o therapeutic drug monitoring.

@ast

Development and validation of ...... o therapeutic drug monitoring.

@en

P1476

Development and validation of ...... o therapeutic drug monitoring.

@en

P2093

Bo Jiang

http://www.w3.org/2001/XMLSchema#string

Hong-gang Lou

http://www.w3.org/2001/XMLSchema#string

Jin-liang Chen

http://www.w3.org/2001/XMLSchema#string

Ling-yan Yu

http://www.w3.org/2001/XMLSchema#string

Rong Shao

http://www.w3.org/2001/XMLSchema#string

Zou-rong Ruan

http://www.w3.org/2001/XMLSchema#string

P2860

A simple, selective and rapid validated method for estimation of anastrazole in human plasma by liquid chromatography-tandem mass spectrometry and its application to bioequivalence study.

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.

Letrozole: a review of its use in postmenopausal women with breast cancer.

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age.

Spectrophotometric methods for the determination of letrozole in bulk and pharmaceutical dosage forms

The discovery and mechanism of action of letrozole.

Reverse phase high performance liquid chromatographic method for the analysis of letrozole in pharmaceutical dosage forms.

Simultaneous quantitative analysis of letrozole, its carbinol metabolite, and carbinol glucuronide in human plasma by LC-MS/MS.

Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.

P304

632-637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BMC.3607

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26317321

http://www.w3.org/2001/XMLSchema#string

Development and validation of a rapid LC-MS/MS method to quantify letrozole in human plasma and its application to therapeutic drug monitoring.

about

P2860

P2860

Development and validation of a rapid LC-MS/MS method to quantify letrozole in human plasma and its application to therapeutic drug monitoring.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698